Protective Effects of Melatonin on Retinal Inflammation and Oxidative Stress in Experimental Diabetic Retinopathy

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Jiang, Tingting ^a,b   Chang, Qing ^a,b   Cai, Jiyang ^c   Fan, Jiawen ^a,b   Zhang, Xiaozhe ^a,b   Xu, Gezhi ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Key Laboratory of Visual Impairment and Restoration   (China)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ANTIOXIDANTS; EYE PROTECTION; NITRIC OXIDE; OPHTHALMOLOGY; OXIDATIVE STRESS; PATHOLOGY; RATS;

ANTI-INFLAMMATORY FUNCTION; DIABETIC RETINOPATHY; ENDOGENOUS HORMONES; GLUTAMATE-CYSTEINE LIGASE; INDUCIBLE NITRIC OXIDE SYNTHASE (INOS); POTENTIAL MECHANISM; PRO-INFLAMMATORY CYTOKINES; RECEPTOR-MEDIATED SIGNALING;

HORMONES;

ANTIINFLAMMATORY AGENT; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; PROTEIN KINASE B; STREPTOZOCIN; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA;

A WAVE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; B WAVE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG MECHANISM; ELECTRORETINOGRAPHY; FLUORESCENCE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA INJURY; RETINITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; SPRAGUE DAWLEY RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; MALE; MELATONIN; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84965166817     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/3528274     Document Type: Article

References (67)

1. R. N. Frank, "Diabetic retinopathy, "The New England Journal of Medicine, vol. 350, no. 1, pp. 48-58, 2004.
2. R. Williams, M. Airey, H. Baxter, J. Forrester, T. Kennedy-Martin, and A. Girach, "Epidemiology of diabetic retinopathy and macular oedema: a systematic review, " Eye, vol. 18, no. 10, pp. 963-983, 2004.
3. R. A. Kowluru and P.-S. Chan, "Oxidative stress and diabetic retinopathy, " Experimental Diabesity Research, vol. 2007, Article ID 43603, 12 pages, 2007.
4. J. Tang and T. S. Kern, "Inflammation in diabetic retinopathy, " Progress in Retinal and Eye Research, vol. 30, no. 5, pp. 343-358, 2011.
5. A. J. Augustin, A. Keller, F. Koch, B. Jurklies, and B. Dick, "Effect of retinal coagulation status on oxidative metabolite and VEGF in 208 patientswith proliferative diabetic retinopathy, " Klinische Monatsblätter für Augenheilkunde, vol. 218, no. 2, pp. 89-94, 2001.
6. D. Bonnefont-Rousselot and F. Collin, "Melatonin: action as antioxidant and potential applications in human disease and aging, " Toxicology, vol. 278, no. 1, pp. 55-67, 2010.
7. A. Galano, D. X. Tan, and R. J. Reiter, "Melatonin as a natural ally against oxidative stress: a physicochemical examination, " Journal of Pineal Research, vol. 51, no. 1, pp. 1-16, 2011.
8. A. Galano, D. X. Tan, and R. J. Reiter, "On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK, " Journal of Pineal Research, vol. 54, no. 3, pp. 245-257, 2013.
9. A. Romero, E. Ramos, C. de Los Ríos, J. Egea, J. DelPino, and R. J. Reiter, "A review of metal-catalyzed molecular damage: protection by melatonin, " Journal of Pineal Research, vol. 56, no. 4, pp. 343-370, 2014.
10. A. Agil, R. J. Reiter, A. Jiménez-Aranda et al., "Melatonin ameliorates low-grade inflammation and oxidative stress in young Zucker diabetic fatty rats, " Journal of Pineal Research, vol. 54, no. 4, pp. 381-388, 2013.
11. G. Negi, A. Kumar, and S. S. Sharma, "Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-. B and Nrf2 cascades, " Journal of Pineal Research, vol. 50, no. 2, pp. 124-131, 2011.
12. J. L. Mauriz, P. S. Collado, C. Veneroso, R. J. Reiter, and J. González-Gallego, "A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives, " Journal of Pineal Research, vol. 54, no. 1, pp. 1-14, 2013.
13. X. Liu, Y. Gong, K. Xiong et al., "Melatonin mediates protective effects on inflammatory response induced by interleukin-1 beta in human mesenchymal stem cells, " Journal of Pineal Research, vol. 55, no. 1, pp. 14-25, 2013.
14. M. Kanter, H. Uysal, T. Karaca, and H. O. Sagmanligil, "Depression of glucose levels and partial restoration of pancreatic-cell damage by melatonin in streptozotocin-induced diabetic rats, " Archives of Toxicology, vol. 80, no. 6, pp. 362-369, 2006.
15. R. A. Derlacz, P. Poplawski, M. Napierala, A. K. Jagielski, and J. Bryla, "Melatonin-induced modulation of glucose metabolism in primary cultures of rabbit kidney-cortex tubules, " Journal of Pineal Research, vol. 38, no. 3, pp. 164-169, 2005.
16. A. Guven, O. Yavuz, M. Cam et al., "Effects of melatonin on streptozotocin-induced diabetic liver injury in rats, " Acta Histochemica, vol. 108, no. 2, pp. 85-93, 2006.
17. M. Gül, S. Emre, M. Eşrefoglu, and N. Vard, "Protective effects of melatonin and aminoguanidine on the cornea in streptozotocin-induced diabetic rats, " Cornea, vol. 27, no. 7, pp. 795-801, 2008.
18. G. Tosini and M. Menaker, "The clock in the mouse retina: melatonin synthesis and photoreceptor degeneration, " Brain Research, vol. 789, no. 2, pp. 221-228, 1998.
19. D. do Carmo Buonfiglio, R. A. Peliciari-Garcia, F. G. do Amaral et al., "Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic wistar rats, " Investigative Ophthalmology and Visual Science, vol. 52, no. 10, pp. 7416-7422, 2011.
20. T. Gürpinar, N. Ekerbiçer, N. Uysal, T. Barut, F. Tarakçi, and M. I. Tuglu, "The effects of the melatonin treatment on the oxidative stress and apoptosis in diabetic eye and brain, " TheScientificWorldJournal, vol. 2012, Article ID 498489, 2012.
21. T. Jiang, Q. Chang, Z. Zhao et al., "Melatonin-mediated cytoprotection against hyperglycemic injury in Müller cells, " PLoS ONE, vol. 7, no. 12, Article IDe50661, 2012.
22. R. B. Caldwell, M. Bartoli, M. A. Behzadian et al., "Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives, " Diabetes/ Metabolism Research and Reviews, vol. 19, no. 6, pp. 442-455, 2003.
23. S. A. Madsen-Bouterse and R. A. Kowluru, "Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives, " Reviews in Endocrine and Metabolic Disorders, vol. 9, no. 4, pp. 315-327, 2008.
24. C. Rodriguez, J. C. Mayo, R. M. Sainz et al., "Regulation of antioxidant enzymes: a significant role for melatonin, " Journal of Pineal Research, vol. 36, no. 1, pp. 1-9, 2004.
25. G. Özdemir, Y. Ergün, S. Bakariş, M. Klnç, H. Durdu, and E. Ganiyusufoglu, "Melatonin prevents retinal oxidative stress and vascular changes in diabetic rats, " Eye, vol. 28, no. 8, pp. 1020-1027, 2014.
26. E. M. Salido, M. Bordone, A. De Laurentiis et al., "Therapeutic efficacy of melatonin in reducing retinal damage in an experimental model of early type 2 diabetes in rats, " Journal of Pineal Research, vol. 54, no. 2, pp. 179-189, 2013.
27. K. H. Jung, S.-W. Hong, H.-M. Zheng, D.-H. Lee, and S.-S. Hong, "Melatonin downregulates nuclear erythroid 2-related factor 2 and nuclear factor-kappaB during prevention of oxidative liver injury in a dimethylnitrosamine model, " Journal of Pineal Research, vol. 47, no. 2, pp. 173-183, 2009.
28. R. J. Reiter, D.-X. Tan, C. Osuna, and E. Gitto, "Actions of melatonin in the reduction of oxidative stress. A review, " Journal of Biomedical Science, vol. 7, no. 6, pp. 444-458, 2000.
29. J. Leon, D. Acuña-Castroviejo, R. M. Sainz, J. C. Mayo, D.-X. Tan, and R. J. Reiter, "Melatonin and mitochondrial function, " Life Sciences, vol. 75, no. 7, pp. 765-790, 2004.
30. R. L. Engerman and T. S. Kern, "Retinopathy in animal models of diabetes, "Diabetes/MetabolismReviews, vol. 11, no. 2, pp. 109-120, 1995.
31. I. G. Obrosova, A. G. Minchenko, R. Vasupuram et al., "Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats, " Diabetes, vol. 52, no. 3, pp. 864-871, 2003.
32. N. Kato, S. Yashima, T. Suzuki, Y. Nakayama, and T. Jomori, "Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats, " Journal of Diabetes and Its Complications, vol. 17, no. 6, pp. 374-379, 2003.
33. S. P. Ayalasomayajula and U. B. Kompella, "Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic ratmodel, " European Journal of Pharmacology, vol. 458, no. 3, pp. 283-289, 2003.
34. Q. Li, E. Zemel, B. Miller, and I. Perlman, "Early retinal damage in experimental diabetes: electroretinographical and morphological observations, " Experimental Eye Research, vol. 74, no. 5, pp. 615-625, 2002.
35. A. Agil, I. Rosado, R. Ruiz, A. Figueroa, N. Zen, and G. Fernández-Vázquez, "Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats, " Journal of Pineal Research, vol. 52, no. 2, pp. 203-210, 2012.
36. M. M. Anwar and A.-R. M. A. Meki, "Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin, " Comparative Biochemistry and Physiology-A Molecular and Integrative Physiology, vol. 135, no. 4, pp. 539-547, 2003.
37. A. K. Natesan and V. M. Cassone, "Melatonin receptor mRNA localization and rhythmicity in the retina of the domestic chick, Gallus domesticus, " Visual Neuroscience, vol. 19, no. 3, pp. 265-274, 2002.
38. A. Sengupta, K. Baba, F. Mazzoni et al., "Localization of Melatonin receptor 1 inmouse retina and its role in the circadian regulation of the electroretinogram and dopamine levels, " PLoS ONE, vol. 6, no. 9, Article ID e24483, 2011.
39. A. F. Wiechmann and J. A. Summers, "Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues, " Progress in Retinal and Eye Research, vol. 27, no. 2, pp. 137-160, 2008.
40. A. M. Mathes, D. Kubulus, J. Weiler et al., "Melatonin receptors mediate improvements of liver function but not of hepatic perfusion and integrity after hemorrhagic shock in rats, " Critical Care Medicine, vol. 36, no. 1, pp. 24-29, 2008.
41. A. Das, M. McDowell, M. J. Pava et al., "The inhibition of apoptosis by melatonin in VSC4. 1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-toxicity involves membrane melatonin receptors, " Journal of Pineal Research, vol. 48, no. 2, pp. 157-169, 2010.
42. T. W. Kensler, N. Wakabayashi, and S. Biswal, "Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway, " Annual Review of Pharmacology and Toxicology, vol. 47, pp. 89-116, 2007.
43. J. Y. Chan and M. Kwong, "Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein, " Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression, vol. 1517, no. 1, pp. 19-26, 2000.
44. R. T. Mulcahy, M. A. Wartman, H. H. Bailey, and J. J. Gipp, "Constitutive and-naphthoflavone-induced expression of the human-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence, " Journal of Biological Chemistry, vol. 272, no. 11, pp. 7445-7454, 1997.
45. Q. Zhong, M. Mishra, and R. A. Kowluru, "Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy, " Investigative Ophthalmology and Visual Science, vol. 54, no. 6, pp. 3941-3948, 2013.
46. L. Wang, Y. Chen, P. Sternberg, and J. Cai, "Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE, " Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1671-1678, 2008.
47. S. Papaiahgari, Q. Zhang, S. R. Kleeberger, H.-Y. Cho, and S. P. Reddy, "Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-P13K-Akt/ERKMAP kinase signaling in pulmonary epithelial cells, "Antioxidants and Redox Signaling, vol. 8, no. 1-2, pp. 43-52, 2006.
48. X. Xi, L. Gao, D. A. Hatala et al., "Chronically elevated glucose-induced apoptosis is mediated by inactivation of Akt in cultured Müller cells, " Biochemical and Biophysical Research Communications, vol. 326, no. 3, pp. 548-553, 2005.
49. Y.-H. Kim, Y.-S. Kim, C.-H. Park et al., "Protein kinase C-mediates neuronal apoptosis in the retinas of diabetic rats via the akt signaling pathway, " Diabetes, vol. 57, no. 8, pp. 2181-2190, 2008.
50. T. Murata, T. Ishibashi, A. Khalil, Y. Hata, H. Yoshikawa, and H. Inomata, "Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels, " Ophthalmic Research, vol. 27, no. 1, pp. 48-52, 1995.
51. T. Qaum, Q. Xu, A. M. Joussen et al., "VEGF-initiated bloodretinal barrier breakdown in early diabetes, " Investigative Ophthalmology and Visual Science, vol. 42, no. 10, pp. 2408-2413, 2001.
52. A. P. Adamis, J. W. Miller, M.-T. Bernal et al., "Increasedvascular endothelial growth factor levels in the vitreous of eyes with proliferativediabetic retinopathy, "American Journal ofOphthalmology, vol. 118, no. 4, pp. 445-450, 1994.
53. C. Kaur, V. Sivakumar, Z. Yong, J. Lu, W. S. Foulds, and E. A. Ling, "Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration, " The Journal of Pathology, vol. 212, no. 4, pp. 429-439, 2007.
54. A. M. Joussen, V. Poulaki, M. L. Le et al., "A central role for inflammation in the pathogenesis of diabetic retinopathy, " The FASEB Journal, vol. 18, no. 12, pp. 1450-1452, 2004.
55. A. Gverovíc Antunica, K. Karaman, L. Znaor, A. Sapunar, V. Busko, and V. Puzovíc, "IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients, " Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 250, no. 6, pp. 815-821, 2012.
56. J. Zhou, S. Wang, and X. Xia, "Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy, " Current Eye Research, vol. 37, no. 5, pp. 416-420, 2012.
57. P. H. Sande, D. Dorfman, D. C. Fernandez et al., "Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation, " British Journal of Pharmacology, vol. 171, no. 24, pp. 5696-5707, 2014.
58. M. Karin, Y. Yamamoto, and Q. M. Wang, "The IKK NF-B system: a treasure trove for drug development, " Nature Reviews Drug Discovery, vol. 3, no. 1, pp. 17-26, 2004.
59. N. Nagai, K. Izumi-Nagai, Y. Oike et al., "Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-B pathway, " Investigative Ophthalmology and Visual Science, vol. 48, no. 9, pp. 4342-4350, 2007.
60. P. H. Sande, D. C. Fernandez, H. J. Aldana Marcos et al., "Therapeutic effect of melatonin in experimental uveitis, " The American Journal of Pathology, vol. 173, no. 6, pp. 1702-1713, 2008.
61. R. Medeiros, R. D. S. Prediger, G. F. Passos et al., "Connecting TNF-signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid protein, " Journal of Neuroscience, vol. 27, no. 20, pp. 5394-5404, 2007.
62. A. Korkmaz, S. Rosales-Corral, and R. J. Reiter, "Gene regulation by melatonin linked to epigenetic phenomena, " Gene, vol. 503, no. 1, pp. 1-11, 2012.
63. P. M. Martin, P. Roon, T. K. Van Ells, V. Ganapathy, and S. B. Smith, "Death of retinal neurons in streptozotocin-induced diabetic mice, " Investigative Ophthalmology and Visual Science, vol. 45, no. 9, pp. 3330-3336, 2004.
64. J. H. Yang, H. W. Kwak, T. G. Kim, J. Han, S. W. Moon, and S. Y. Yu, "Retinal neurodegeneration in type II diabetic Otsuka long-evans Tokushima fatty rats, " Investigative Ophthalmology and Visual Science, vol. 54, no. 6, pp. 3844-3851, 2013.
65. X. Li, M. Zhang, and W. Tang, "Effects of melatonin on streptozotocin-induced retina neuronal apoptosis in high blood glucose rat, " Neurochemical Research, vol. 38, no. 3, pp. 669-676, 2013.
66. S. W. Park, H. S. Lee, M. S. Sung, and S. J. Kim, "The effect of melatonin on retinal ganglion cell survival in ischemic retina, " Chonnam Medical Journal, vol. 48, no. 2, pp. 116-122, 2012.
67. C. Yi, X. Pan, H. Yan, M. Guo, and W. Pierpaoli, "Effects of melatonin in age-related macular degeneration, " Annals of the New York Academy of Sciences, vol. 1057, pp. 384-392, 2005.